Clinical Trial Update: Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

View source ↗

Summary

An observational study of Sifrol (pramipexole) in patients with primary restless legs syndrome has completed, according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Sifrol (ropinirole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Status: COMPLETED